InsidersTradesSigma
Track the 선바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 선바이오 has recorded 10 reports. Market capitalisation: €78.7bn. The latest transaction was disclosed on 23 April 2026 (Purchase). Among the most active insiders: 노광. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10 of 10 declarations
Sunbio operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the healthcare field.